Effects of intraventricular dynorphin treatment on brain monoamines

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Dynorphin was administered into the lateral cerebral ventricle of rats and its effects were measured 60 min later on the noradrenaline (NA), dopamine (DA) and serotonin (5-HT) contents of various brain regions. Dynorphin decreased the NA, DA and 5-HT contents of the hypothalamus as well as the 5-HT content of the caudate nucleus. These effects were not manifested after naloxone pretreatment. In the frontal cortex and in the septum, dynorphin caused a naloxone-insensitive increase in the 5-HT content, and the increased caudate DA content was not antagonized by the opiate receptor antagonist either. The data suggest that dynorphin affects cerebral monoaminergic neurotransmission. The changes of the largest magnitude occured in the hypothalamus. Only some of these effects were antagonized by naloxone, suggesting that the CNS effects of dynorphin are only partly mediated by endogenous opioid binding sites.

Original languageEnglish
Pages (from-to)371-375
Number of pages5
JournalNeuropeptides
Volume1
Issue number5
DOIs
Publication statusPublished - Jun 1981

ASJC Scopus subject areas

  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Effects of intraventricular dynorphin treatment on brain monoamines'. Together they form a unique fingerprint.

  • Cite this